Osteoarthritis

Comparative risks of mortality and fractures in patients with osteoarthritis initiating tramadol versus other opioids

Arthritis RheumatolPublished retrospective cohort study

Authors' conclusion

In adults aged 50 years or older with osteoarthritis initiating an opioid, tramadol initiation was associated with lower risks of mortality and fractures compared with hydrocodone and oxycodone, and similar risks compared with codeine. These findings suggest that tramadol may be a comparatively favorable option when opioid therapy is necessary, although its longer-term comparative safety remains uncertain.

Study context

Population
Adults aged ≥50 years with osteoarthritis initiating tramadol, codeine, hydrocodone, or oxycodone, Optum Clinformatics® Data Mart (2005–2021)mean age 69.1 years, 62.5% female
Participants
1,057,635 adults
Exposure
Tramadol versus other prescribed opioids
  • Tramadoln = 294,760
  • Codeinen = 97,048reference
  • Hydrocodonen = 474,733reference
  • Oxycodonen = 191,094reference
Outcome
All-cause mortality
Methodological detailsPropensity score weighting, weighted Cox proportional hazards models
  • Propensity score weighting
  • Weighted Cox proportional hazards models

Main finding

As reported in the abstract

Hazard ratio (95% CI)
Tramadolvs Codeinesimilar mortality risk
0.93(0.73–1.19)
Tramadolvs Hydrocodonelower risk
0.81(0.70–0.93)
Tramadolvs Oxycodonelower risk
0.40(0.34–0.47)
Deaths during follow-up
9,988

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
FracturesTramadolvs CodeineComparable1.10 (0.96–1.25)
FracturesTramadolvs Hydrocodone0.91 (0.83–0.98)
FracturesTramadolvs Oxycodone0.83 (0.75–0.93)
Fractures — Fractures during follow-up
10,455

Original publication

Comparative risks of mortality and fractures in patients with osteoarthritis initiating tramadol versus other opioids. Arthritis Rheumatol. Published 27 October 2026. doi:10.1002/art.70383

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.